Intech Investment Management LLC Sells 78,037 Shares of Humana Inc. (NYSE:HUM)

Intech Investment Management LLC trimmed its holdings in shares of Humana Inc. (NYSE:HUM) by 68.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 36,172 shares of the insurance provider’s stock after selling 78,037 shares during the period. Intech Investment Management LLC’s holdings in Humana were worth $9,177,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the business. Generali Asset Management SPA SGR bought a new position in shares of Humana in the fourth quarter valued at about $1,948,000. Kennondale Capital Management LLC bought a new position in shares of Humana in the fourth quarter worth about $7,056,000. Retirement Planning Co of New England Inc. lifted its position in shares of Humana by 4.7% during the fourth quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider’s stock worth $245,000 after purchasing an additional 43 shares in the last quarter. William Blair Investment Management LLC grew its stake in shares of Humana by 13.7% during the fourth quarter. William Blair Investment Management LLC now owns 18,045 shares of the insurance provider’s stock valued at $4,578,000 after purchasing an additional 2,172 shares during the last quarter. Finally, Cibc World Markets Corp increased its holdings in shares of Humana by 16.3% in the fourth quarter. Cibc World Markets Corp now owns 19,012 shares of the insurance provider’s stock valued at $4,824,000 after purchasing an additional 2,660 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently commented on HUM. Truist Financial lifted their target price on Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research note on Monday, January 6th. JPMorgan Chase & Co. dropped their price objective on Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a report on Tuesday, February 18th. Barclays raised their target price on shares of Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a research note on Thursday, February 13th. Royal Bank of Canada restated an “outperform” rating and issued a $283.00 price objective on shares of Humana in a report on Wednesday, February 12th. Finally, Piper Sandler lifted their target price on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a report on Wednesday, January 15th. Nineteen investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $285.68.

Insider Activity at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the transaction, the insider now directly owns 8,181 shares of the company’s stock, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.37% of the stock is owned by insiders.

Humana Stock Performance

Shares of HUM opened at $269.86 on Wednesday. The firm has a market cap of $32.57 billion, a P/E ratio of 27.12, a PEG ratio of 2.05 and a beta of 0.57. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $406.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The firm’s 50 day moving average price is $271.45 and its two-hundred day moving average price is $278.29.

Humana (NYSE:HUM) last posted its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.31%. Humana’s payout ratio is presently 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.